주식/증권
📈 긍정적
ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand
요약
ICCC posts record Q1 sales and 34% earnings growth as demand for its First Defense calf-health products boosts margins and market share.